Results 241 to 250 of about 17,573,077 (386)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Model-agnostic neural mean field with a data-driven transfer function. [PDF]

open access: yesNeuromorphic Comput Eng
Spaeth A, Haussler D, Teodorescu M.
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Probabilistic neural transfer function estimation with Bayesian system identification. [PDF]

open access: yesPLoS Comput Biol
Wu N   +5 more
europepmc   +1 more source

Phospholipid transfer function of PTPIP51 at mitochondria-associated ER membranes. [PDF]

open access: yesEMBO Rep, 2021
Yeo HK   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy